Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1999 1
2000 1
2002 1
2003 1
2004 1
2005 1
2006 6
2007 2
2008 3
2009 3
2010 7
2011 5
2012 8
2013 5
2014 8
2015 10
2016 14
2017 13
2018 8
2019 7
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32165359

96 results
Results by year
Filters applied: . Clear all
Page 1
Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies.
Hoxworth JM, Eschbacher JM, Gonzales AC, Singleton KW, Leon GD, Smith KA, Stokes AM, Zhou Y, Mazza GL, Porter AB, Mrugala MM, Zimmerman RS, Bendok BR, Patra DP, Krishna C, Boxerman JL, Baxter LC, Swanson KR, Quarles CC, Schmainda KM, Hu LS. Hoxworth JM, et al. AJNR Am J Neuroradiol. 2020 Mar;41(3):408-415. doi: 10.3174/ajnr.A6486. Epub 2020 Mar 12. AJNR Am J Neuroradiol. 2020. PMID: 32165359
Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
Hu LS, Kelm Z, Korfiatis P, Dueck AC, Elrod C, Ellingson BM, Kaufmann TJ, Eschbacher JM, Karis JP, Smith K, Nakaji P, Brinkman D, Pafundi D, Baxter LC, Erickson BJ. Hu LS, et al. AJNR Am J Neuroradiol. 2015 Dec;36(12):2242-9. doi: 10.3174/ajnr.A4451. Epub 2015 Sep 10. AJNR Am J Neuroradiol. 2015. PMID: 26359151 Free PMC article.
Perfusion MRI-Based Fractional Tumor Burden Differentiates between Tumor and Treatment Effect in Recurrent Glioblastomas and Informs Clinical Decision-Making.
Iv M, Liu X, Lavezo J, Gentles AJ, Ghanem R, Lummus S, Born DE, Soltys SG, Nagpal S, Thomas R, Recht L, Fischbein N. Iv M, et al. AJNR Am J Neuroradiol. 2019 Oct;40(10):1649-1657. doi: 10.3174/ajnr.A6211. Epub 2019 Sep 12. AJNR Am J Neuroradiol. 2019. PMID: 31515215 Free PMC article.
Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma.
Sadeghi N, Salmon I, Decaestecker C, Levivier M, Metens T, Wikler D, Denolin V, Rorive S, Massager N, Baleriaux D, Goldman S. Sadeghi N, et al. AJNR Am J Neuroradiol. 2007 Mar;28(3):455-61. AJNR Am J Neuroradiol. 2007. PMID: 17353312 Free article.
Glioma Angiogenesis and Perfusion Imaging: Understanding the Relationship between Tumor Blood Volume and Leakiness with Increasing Glioma Grade.
Jain R, Griffith B, Alotaibi F, Zagzag D, Fine H, Golfinos J, Schultz L. Jain R, et al. AJNR Am J Neuroradiol. 2015 Nov;36(11):2030-5. doi: 10.3174/ajnr.A4405. Epub 2015 Jul 23. AJNR Am J Neuroradiol. 2015. PMID: 26206809 Free article.
Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Law M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, Miller DC, Golfinos JG, Zagzag D, Johnson G. Law M, et al. Radiology. 2008 May;247(2):490-8. doi: 10.1148/radiol.2472070898. Epub 2008 Mar 18. Radiology. 2008. PMID: 18349315 Free PMC article.
Posttreatment high-grade glioma: usefulness of peak height position with semiquantitative MR perfusion histogram analysis in an entire contrast-enhanced lesion for predicting volume fraction of recurrence.
Kim HS, Kim JH, Kim SH, Cho KG, Kim SY. Kim HS, et al. Radiology. 2010 Sep;256(3):906-15. doi: 10.1148/radiol.10091461. Epub 2010 Jul 15. Radiology. 2010. PMID: 20634429
Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma.
Prah MA, Stufflebeam SM, Paulson ES, Kalpathy-Cramer J, Gerstner ER, Batchelor TT, Barboriak DP, Rosen BR, Schmainda KM. Prah MA, et al. AJNR Am J Neuroradiol. 2015 Sep;36(9):1654-61. doi: 10.3174/ajnr.A4374. Epub 2015 Jun 11. AJNR Am J Neuroradiol. 2015. PMID: 26066626 Free PMC article.
Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
Law M, Young R, Babb J, Rad M, Sasaki T, Zagzag D, Johnson G. Law M, et al. AJNR Am J Neuroradiol. 2006 Oct;27(9):1975-82. AJNR Am J Neuroradiol. 2006. PMID: 17032878 Free article.
Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
Hussain NS, Moisi MD, Keogh B, McCullough BJ, Rostad S, Newell D, Gwinn R, Foltz G, Mayberg M, Aguedan B, Good V, Fouke SJ. Hussain NS, et al. J Neurosurg. 2017 Apr;126(4):1220-1226. doi: 10.3171/2016.3.JNS14243. Epub 2016 Jun 10. J Neurosurg. 2017. PMID: 27285539
96 results
Jump to page
Feedback